Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Henry Friedman, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01639612
First received: June 28, 2012
Last updated: April 19, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)